Upon completion of this conference attendees will be able to:
Identify emerging and established evidence-based treatment options for a range of malignancies including lung, breast, GI, GU, melanoma, head and neck, and hematologic cancers such as multiple myeloma, NHL, AML, and CLL
Evaluate current clinical guidelines and standard-of-care practices across disciplines in the management of both solid and hematologic malignancies
Collaborate effectively within an interprofessional care team to develop individualized, multidisciplinary treatment plans for patients undergoing combined-modality therapy (e.g., surgery, radiation, systemic therapy)
Apply best practices in symptom management and supportive care for oncology patients, with attention to the recognition and mitigation of treatment-related adverse effects such as autoimmune toxicity, hematologic complications, and metabolic disturbances
Incorporate molecular profiling and patient-specific factors to tailor oncology treatment strategies that enhance outcomes and reduce harm